Baraclude and Lactic acidosis - a phase IV clinical study of FDA data

Summary:

Lactic acidosis is reported as a side effect among people who take Baraclude (entecavir), especially for people who are male, 50-59 old, have been taking the drug for < 1 month also take Sandimmune, and have Diabetes.

The phase IV clinical study analyzes which people have Lactic acidosis when taking Baraclude. It is created by eHealthMe based on reports of 6,115 people who have side effects when taking Baraclude from the FDA, and is updated regularly.

What is Baraclude?

Baraclude has active ingredients of entecavir. It is often used in hepatitis b. eHealthMe is studying from 6,175 Baraclude users. Check the latest studies of Baraclude.

What is Lactic acidosis?

Lactic acidosis (low ph in body tissues) is found to be associated with 997 drugs and 1,276 conditions by eHealthMe. Check the latest studies of Lactic acidosis.

On Jul, 07, 2026

6,115 people reported to have side effects when taking Baraclude.
Among them, 65 people (1.06%) have Lactic acidosis.

Among these 65 people:

How long have people been on Baraclude when they have Lactic acidosis? *

What is the gender of people who have Lactic acidosis when taking Baraclude? *

female: 18.87 %
male: 81.13 %

What is the age of people who have Lactic acidosis when taking Baraclude? *

What are other drugs people take besides Baraclude? *

Sandimmune: 6 people, 9.23%
Solu-Medrol: 5 people, 7.69%
Lactulose: 5 people, 7.69%
Famotidine: 5 people, 7.69%
Cellcept: 4 people, 6.15%
Hepsera: 3 people, 4.62%
Pantoprazole Sodium: 3 people, 4.62%
Glucophage: 3 people, 4.62%
Tenofovir Disoproxil Fumarate: 3 people, 4.62%
Cosopt: 3 people, 4.62%

What are other side effects people have besides Lactic acidosis? *

Acute Kidney Failure: 15 people, 23.08%
Pneumonia: 9 people, 13.85%
Muscle Aches (muscle pain): 5 people, 7.69%
Hepatic Failure (liver failure): 5 people, 7.69%
Fever: 4 people, 6.15%
Weakness: 3 people, 4.62%
Blood Creatine Phosphokinase Increased: 3 people, 4.62%
Cardio-Respiratory Arrest (sudden dysfunction of heart and lungs): 3 people, 4.62%
Cytokine Release Syndrome (immediate complication occurring with the use of anti-t cell antibody infusions): 3 people, 4.62%
Disease Progression: 3 people, 4.62%

What are the existing conditions these people have? *

Diabetes: 5 people, 7.69%
Type 2 Diabetes: 3 people, 4.62%
Glaucoma (increased fluid pressure in the eye with vision loss): 3 people, 4.62%
Burkitt Lymphoma (cancer of the lymphatic system): 3 people, 4.62%
Ventricular Tachyarrhythmia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart): 2 people, 3.08%
Ventricular Tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart): 1 person, 1.54%
Ventricular Arrhythmia (problem with the rate or rhythm of the heartbeat): 1 person, 1.54%
Stress And Anxiety: 1 person, 1.54%
Platelet Aggregation Inhibition: 1 person, 1.54%
High Blood Pressure: 1 person, 1.54%

* Approximation only. Some reports may have incomplete information.

Do you take Baraclude and have Lactic acidosis?

- Check whether Lactic acidosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Baraclude:

Baraclude (6,175 reports)

Lactic acidosis treatments and more:

Lactic acidosis (34,314 reports)

Browse all side effects of Baraclude:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Lactic acidosis:

Lactic acidosis (997 drugs)

Browse all the conditions that are associated with Lactic acidosis:

Lactic acidosis (1,276 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on entecavir (the active ingredients of Baraclude) and Baraclude (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.